Department of Clinical Cancer Studies
Our work encompasses the full range of clinical cancer research, from first-in-human studies to phase 4 studies. The CCS is a key part of the accredited Karolinska Comprehensive Cancer Center.
The Clinical Cancer Studies consists of five organizational subunits:
- Cancer study Unit Solna
- Cancer study Unit Huddinge
- Phase 1 Unit Solna
- Phase 1 Unit Huddinge
- Clinical Trials Office
Collaboration Partners
CCS maintains robust partnerships with various departments both within and external to the hospital, enhancing our multidisciplinary approach to cancer care and research. These collaborations span a wide range of specialties, including Medical Imaging, Nuclear Medicine, Pathology, Clinical Chemistry, Clinical Physiology, Pharmacy, Intensive Care Units (ICU), and the hospital's Advanced Therapy Medicinal Products (ATMP) unit.
Facilities
Cancer study Unit Solna
The unit consists of research nurses and assistant nurses who, together with responsible investigators conduct clinical studies (phase 2-4) on all types of cancer.
Cancer study Unit Huddinge
The unit consists of research nurses and assistant nurses who, together with responsible investigators conduct clinical studies (phase 1-4) with a focus on Hematological and Upper Gastrointestinal studies.
Phase 1 Unit Solna
The unit consists of research nurses, assistant nurses, and dedicated phase 1 physicians. The unit has the facilities for overnight stays and extensive pharmacokinetic blood sampling 24/7. At the Phase 1 Unit Solna, first-in-human and other early clinical cancer trials studies are carried out.
Phase 1 Unit Huddinge
The unit consists of research nurses, assistant nurses and dedicated phase 1 physicians. The unit has the facilities for overnight stays and extensive pharmacokinetic blood sampling 24/7.
The Phase 1 Unit Huddinge performs early clinical trials in healthy volunteer studies as well studies in medical disciplines apart from oncology.
Clinical Trial Office
Clinical Trial Offices offer support for non-commercial, academic clinical drug trials and studies. We provide our physicians and researchers with assistance in writing study protocols, submitting applications to the appropriate authorities, project support, monitoring, data management, pharmacovigilance, creating electronic Case Report Forms (eCRFs), web-based randomization, and even coordinating multicenter national and international projects.
Our team possesses expertise and experience in project support across a broad range of therapeutic areas, including oncology, hematology, urology, immunology, cell therapy, infectious diseases, pediatrics, rare diseases, neurology, radiotherapy, and medical technology.